Evidence map›Paper›PMID 24509782›Full record

ReviewNature reviews. Microbiology2014

Molecular mechanisms of varicella zoster virus pathogenesis.

Leigh Zerboni, Nandini Sen, Stefan L Oliver, Ann M Arvin

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03862092 (Frequency of Putative Enteric Zoster Diagnosed Using Saliva Samples in Patients With Abdominal Pain), which is not on this map. Cited by 266 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
266citing papers in PubMed, 1 pooled it
18.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03862092 nacompletednot on this mapstarted 2019, after this paper: background citation

Frequency of Putative Enteric Zoster Diagnosed Using Saliva Samples in Patients With Abdominal Pain: a Prospective Study

TypeinterventionalSponsorAsan Medical CenterRan2019 to 2019Enrolled50ConditionsAbdominal Pain, Zoster With Other ComplicationsArmsSalivary VZV-DNA PCR
3 · Its place in the literature

Who cites it

266 citing papers in PubMed, 1 synthesis or guideline pooled it, 461 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Development of mRNA vaccines against herpes zoster.Human vaccines & immunotherapeutics · 2026
    Review
  8. Article
  9. Review
  10. Varicella zoster virus infection.Nature reviews. Disease primers · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Varicella zoster virus and the central nervous system.Nature reviews. Microbiology · 2026
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

206 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Leigh ZerboniDepartments of Pediatrics and of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Nandini SenDepartments of Pediatrics and of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Stefan L OliverDepartments of Pediatrics and of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Ann M ArvinDepartments of Pediatrics and of Microbiology & Immunology, Stanford University School of Medicine, Stanford, California 94305, USA.
Stanford University · US

Funding

Varicella-Zoster Virus: T Cell/Skin Tropisms &ImmunityR01AI020459 · NIAID · STANFORD UNIVERSITY · PI OLIVER, STEFAN LYNE · 1985 to 2023
$6.4M
Varicella-zoster Virus: Tegument Proteins in PathogenesisR01AI053846 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2003 to 2012
$4.1M
Varicella-Zoster Virus: T Cell/Skin Tropisms & ImmunityR37AI020459 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2016 to 2020
$2.0M
Varicella zoster virus: molecular controls of cell fusion-dependent pathogenesisR01AI102546 · NIAID · STANFORD UNIVERSITY · PI ARVIN, ANN · 2012 to 2016
$1.9M
NIAID NIH HHS AI05346NIAID NIH HHS AI102546NIAID NIH HHS AI20459NIAID NIH HHS R01 AI020459NIAID NIH HHS R01 AI053846NIAID NIH HHS R01 AI102546NIAID NIH HHS R37 AI020459
6 · The paper itself

Abstract

Varicella zoster virus (VZV) is the causative agent of varicella (chickenpox) and zoster (shingles). Investigating VZV pathogenesis is challenging as VZV is a human-specific virus and infection does not occur, or is highly restricted, in other species. However, the use of human tissue xenografts in mice with severe combined immunodeficiency (SCID) enables the analysis of VZV infection in differentiated human cells in their typical tissue microenvironment. Xenografts of human skin, dorsal root ganglia or foetal thymus that contains T cells can be infected with mutant viruses or in the presence of inhibitors of viral or cellular functions to assess the molecular mechanisms of VZV-host interactions. In this Review, we discuss how these models have improved our understanding of VZV pathogenesis.

Indexed as

Host-Pathogen InteractionsAnimalsChickenpoxDisease Models, AnimalHerpesvirus 3, HumanHerpes ZosterHeterograftsHumansMiceMice, SCIDMutationViral Tropism

Identifiers

PMID24509782
PMCPMC4066823
OpenAlexW2076628448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.